PolarityTE, Inc. , a biotechnology company developing regenerative tissue products and biomaterials, announced the U.S. Patent and Trademark Office (USPTO) recently issued a Notice...
Immunic, Inc., a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced that...
